Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.

Abstract

This screening protocol is highly specific for ovarian cancer and can detect a substantial proportion of cases at a preclinical stage. Further investigation is required to determine the effect of the screening protocol on the ratio of early to late stage disease detected and on mortality from ovarian cancer.